Humacyte HUMA
NASDAQ HUMA
$0.41 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Humacyte (HUMA) Cash & Current Investments (2020 - 2026)

Updated

Humacyte's Cash & Current Investments was $79.9 million in Q2 2026, up 110.1% from $38.03 million a year earlier and up 64.6% from the prior quarter.

Analysis

Humacyte (HUMA) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Humacyte came in at $50.5 million, up 12.4% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of 4.8% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $44.94 million in FY2024 (-44.1%), $80.45 million in FY2023 (-47.0%), $151.88 million in FY2022 (-32.6%) and $225.5 million in FY2021 (+464.8%).
  • The Q2 2026 figure marks the highest quarterly Cash & Current Investments since Q2 2024.
  • Compared with a year earlier, Cash & Current Investments was higher in two of the last eight quarters, with an average decline of 16.8%.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q4 2021 (growth of 464.8%); the worst was Q3 2024 (a decline of 79.4%).
  • Per Business Quant data, HUMA's Cash & Current Investments in the three quarters before Q2 2026 was $48.54 million (Q1 2026), $50.5 million (Q4 2025) and $19.5 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,141.09 Bn 1,109.67 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.15 Bn 555.01 Bn 17.30 Bn 17.23 Bn
3 AbbVie 501.95 Bn 475.07 Bn 12.70 Bn 6.57 Bn
4 Merck 356.40 Bn 310.78 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 300.55 Bn 264.54 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 263.27 Bn 236.95 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.82 Bn 193.22 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.11 Bn 168.30 Bn 6.22 Bn 3.18 Bn
9 Pfizer 170.27 Bn 116.91 Bn 10.94 Bn 11.70 Bn
10 Humacyte 95.38 Mn -103.06 Mn -825,000.00 79.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 79.90 Mn
Mar 31, 2026 48.54 Mn
Dec 31, 2025 50.50 Mn
Sep 30, 2025 19.50 Mn
Jun 30, 2025 38.03 Mn
Mar 31, 2025 62.85 Mn
Dec 31, 2024 44.94 Mn
Sep 30, 2024 20.60 Mn
Jun 30, 2024 93.60 Mn
Mar 31, 2024 115.51 Mn
Dec 31, 2023 80.45 Mn
Sep 30, 2023 100.00 Mn
Jun 30, 2023 114.60 Mn
Mar 31, 2023 131.68 Mn
Dec 31, 2022 151.88 Mn
Sep 30, 2022 171.73 Mn
Jun 30, 2022 189.04 Mn
Mar 31, 2022 206.22 Mn
Dec 31, 2021 225.50 Mn
Sep 30, 2021 240.45 Mn
API Access

Humacyte Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=HUMA&period=max&api_key=YOUR_API_KEY